Biocompatibility Studies on a Collagen-Hydroxyapatite Biomaterial.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Orthopedic Surgery

Background:

• Osteomyelitis treatment involves antibiotics and debridement, with limitations.
• Bone defect fillers and therapeutic agent delivery systems are crucial.
• Current scaffolds aim to improve drug delivery and bone regeneration.

Purpose of the Study:

• To assess the biocompatibility of a novel microporous biocomposite scaffold.
• The scaffold is composed of hydroxyapatite and a collagen matrix.
• It incorporates therapeutic agents like ciprofloxacin and gentamicin.

Main Methods:

• Synthesized a microporous biocomposite scaffold via hydroxyapatite co-precipitation on a collagen matrix.
• Tested the biocompatibility of the scaffold using cellular cultures.
• Incorporated ciprofloxacin and gentamicin as therapeutic agents within the scaffold.

Main Results:

• The hydroxyapatite/collagen biocomposite scaffold demonstrated good biocompatibility in cellular cultures.
• The scaffold structure is suitable for incorporating therapeutic agents.
• The synthesis method (direct mineralization) is effective for creating the composite.

Conclusions:

• The developed biocomposite scaffold shows promise for osteomyelitis treatment.
• It offers a potential dual function: bone defect filling and localized antibiotic delivery.
• Further in vivo studies are warranted to confirm efficacy and safety.